Robert Maxey
9Patents
3h-index
31Co-inventors
53Inventor score
Filing activity: Mar 1, 2000 → Nov 5, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7176203B2 | Imidazo-triazine derivatives as ligands for gaba receptors | Human Necessities | 59 | Expired |
| US7030128B2 | Imidazo-pyrimidine derivatives as ligands for GABA receptors | Human Necessities | 6 | Expired |
| US6730681B2 | Triazolo-pyrimidine derivatives as ligands for gaba receptors | Human Necessities | 4 | Expired |
| US6900209B2 | Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition | Human Necessities | 3 | Expired |
| US7094777B2 | 5-HT2A receptor ligands | Chemistry; Metallurgy | 2 | Expired |
| US6316468A | Phenylindole derivatives as 5-HT2A receptor antagonists | Chemistry; Metallurgy | 2 | Expired |
| US9981916B2 | Pyridazine derivatives as RORc modulators | Chemistry; Metallurgy | 1 | Active |
| US7144887B2 | Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition | Human Necessities | 1 | Expired |
| US7592456B2 | Arylsulfonylnaphthalene derivatives as 5HT2A antagonists | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.